Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort

被引：15
|
作者：
Kuboki, Y. [1 ]
Yaeger, R. [2 ]
Fakih, M. G. [3 ]
Strickler, J. H. [4 ]
Masuishi, T. [5 ]
Kim, E. J. [6 ]
Bestvina, C. M. [7 ]
Langer, C. J. [8 ]
Krauss, J. C. [9 ]
Puri, S. [10 ]
Cardona, P. [11 ]
Chan, E. [12 ]
Tran, Q. [12 ]
Hong, D. S. [13 ]
机构：
[1] Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, Japan
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[3] City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA
[4] Duke Univ, Dept Med, Med Ctr, Durham, NC USA
[5] Aichi Canc Ctr Hosp, Clin Oncol Dept, Nagoya, Aichi, Japan
[6] UC Davis Comprehens Canc Ctr, Hematol Oncol Internal Med, Sacramento, CA USA
[7] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL USA
[8] Univ Penn, Hematol Oncol, Philadelphia, PA USA
[9] Univ Michigan, Hematol Oncol Internal Med, Ann Arbor, MI USA
[10] Huntsman Canc Inst, Med Hematol & Oncol, Salt Lake City, UT USA
[11] Amgen Inc, Clin Pharmacol Modeling & Simulat, Thousand Oaks, CA USA
[12] Amgen Inc, Res & Dev, Thousand Oaks, CA USA
[13] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.453
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315O
引用
收藏
页码：S680 / S681
页数：2
相关论文
共 50 条
  • [31] Sotorasib treatment in KRAS G12C-mutated non-small cell lung cancer: Experience in the Tours university hospital
    Bessy, C.
    Blin, T.
    Pichon, E.
    Marchand-Adam, S.
    Carmier, D.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (01) : 17 - 23
  • [32] Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
    Strickler, J. H.
    Satake, H.
    George, T. J.
    Yaeger, R.
    Hollebecque, A.
    Garrido-Laguna, I.
    Schuler, M.
    Burns, T. F.
    Coveler, A. L.
    Falchook, G. S.
    Vincent, M.
    Sunakawa, Y.
    Dahan, L.
    Bajor, D.
    Rha, S. -Y.
    Lemech, C.
    Juric, D.
    Rehn, M.
    Ngarmchamnanrith, G.
    Jafarinasabian, P.
    Tran, Q.
    Hong, D. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01): : 33 - 43
  • [33] Sotorasib for KRAS p.G12C-mutated advanced pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 213 - 213
  • [34] Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
    Skoulidis, Ferdinandos
    Li, Bob T.
    Hochmair, Maximilian
    Govindan, Ramaswamy
    Vincent, Mark
    van der Wekken, Anthonie J.
    Reguart Aransay, Noemi
    O'Byrne, Kenneth J.
    Girard, Nicolas
    Griesinger, Frank
    Nishio, Makoto
    Haefliger, Simon
    Lindsay, Colin
    Reinmuth, Niels
    Paulus, Astrid
    Papakotoulas, Pavlos
    Kim, Sang-We
    Ferreira, Carlos Gil
    Pasello, Giulia
    Duruisseaux, Michael
    Gennatas, Spyridon
    Dimou, Anastasios
    Mehta, Bhakti
    Kormany, William
    Nduka, Chidozie
    Sylvester, Brooke E.
    Ardito-Abraham, Christine
    Wang, Yang
    de Langen, Adrianus Johannes
    ONCOLOGIST, 2025, 30 (01):
  • [35] KRAS G12C inhibition with sotorasib in metastatic colorectal cancer
    Severi, Christophe
    Van Cutsem, Eric
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2792 - 2795
  • [36] Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case Report
    Kunimasa, Kei
    Tamiya, Motohiro
    Inoue, Takako
    Kawamura, Takahisa
    Nishino, Kazumi
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (01):
  • [37] Cost-Effectiveness Analysis of Sotorasib vs. Adagrasib in KRAS G12c-Mutated Previously Treated NSCLC
    Karim, N.
    Waterhouse, D.
    Jones, S.
    Stollenwerk, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S719 - S720
  • [38] Sotorasib Shows Intracranial Activity in Patients with KRAS G12C-Mutated Adenocarcinoma of the Lung and Untreated Active Brain Metastases
    Koster, Kira-Lee
    Appenzeller, Christina
    Lauber, Arno
    Fruh, Martin
    Schmid, Sabine
    CASE REPORTS IN ONCOLOGY, 2022, 15 (02): : 720 - 725
  • [39] KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen
    Ciner, Aaron
    Ardalan, Bach
    Baca, Yasmine
    Darabi, Sourat
    Kasi, Anup
    Lou, Emil
    Azqueta, Jose Ignacio
    Xiu, Joanne
    Nabhan, Chadi
    Shields, Anthony F.
    Aguirre, Andrew
    Singh, Harshabad
    Shroff, Rachna T.
    Pishvaian, Michael J.
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Prolonged Cancer Control With Adagrasib in Patients With Metastatic, KRAS G12C-Mutated NSCLC After Sotorasib-Induced Hepatotoxicity: A Case Report
    Stratton, Natalie
    Thompson, Jonathan
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (04):
12345